Literature DB >> 26027015

Separation of enantiomers using vancomycin in a countercurrent process by suppression of electroosmosis.

T J Ward, C Dann, A P Brown.   

Abstract

Excellent separations were achieved using a coated column to suppress electroosmotic flow and employing a countercurrent process between chiral selector and racemic solute. Using the macrocyclic antibiotic vancomycin as a chiral selector in capillary electrophoresis the resolution of nonsteroidal anti inflammatories and dansyl amino acids was achieved. Improvement in sensitivity due to the elimination of background absorbance and increased efficiency due to the removal of wall adsorption effects are both achieved using this technique.

Entities:  

Year:  1996        PMID: 26027015     DOI: 10.1002/(sici)1520-636x(1996)8:1<77::aid-chir13>3.0.co;2-p

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  5 in total

Review 1.  Capillary electrophoresis in pharmaceutical analysis.

Authors:  L A Holland; N P Chetwyn; M D Perkins; S M Lunte
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

2.  Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelf-life and pharmacology.

Authors:  A A van Sorge; P H Wijnen; J L van Delft; V M Coré-Bodelier; N J van Haeringen
Journal:  Pharm World Sci       Date:  1999-04

Review 3.  The Use of Antibiotics as Chiral Selectors in Capillary Electrophoresis: A Review.

Authors:  Gabriel Hancu; Lajos Attila Papp; Blanka Szekely-Szentmiklosi; Hajnal Kelemen
Journal:  Molecules       Date:  2022-06-03       Impact factor: 4.927

Review 4.  Pharmacological importance of stereochemical resolution of enantiomeric drugs.

Authors:  M R Islam; J G Mahdi; I D Bowen
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.228

5.  Comparison of local anesthetic-cyclodextrin non-covalent complexes using capillary electrophoresis and electrospray ionization mass spectrometry.

Authors:  Yazen Al-nouti; Michael G Bartlett
Journal:  J Am Soc Mass Spectrom       Date:  2002-08       Impact factor: 3.109

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.